Ionis Pharmaceuticals Inc (IONS)
38.76
+0.37
(+0.96%)
USD |
NASDAQ |
Nov 01, 16:00
38.76
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Price to Book Value: 23.18 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 23.18 |
| October 31, 2024 | 22.96 |
| October 30, 2024 | 23.48 |
| October 29, 2024 | 23.75 |
| October 28, 2024 | 24.14 |
| October 25, 2024 | 23.44 |
| October 24, 2024 | 23.19 |
| October 23, 2024 | 22.98 |
| October 22, 2024 | 23.13 |
| October 21, 2024 | 23.32 |
| October 18, 2024 | 23.73 |
| October 17, 2024 | 23.02 |
| October 16, 2024 | 23.42 |
| October 15, 2024 | 22.63 |
| October 14, 2024 | 23.10 |
| October 11, 2024 | 22.99 |
| October 10, 2024 | 22.70 |
| October 09, 2024 | 22.76 |
| October 08, 2024 | 22.61 |
| October 07, 2024 | 22.64 |
| October 04, 2024 | 22.67 |
| October 03, 2024 | 22.61 |
| October 02, 2024 | 23.55 |
| October 01, 2024 | 23.37 |
| September 30, 2024 | 23.96 |
| Date | Value |
|---|---|
| September 27, 2024 | 24.43 |
| September 26, 2024 | 24.58 |
| September 25, 2024 | 24.52 |
| September 24, 2024 | 24.52 |
| September 23, 2024 | 25.02 |
| September 20, 2024 | 25.57 |
| September 19, 2024 | 25.56 |
| September 18, 2024 | 25.33 |
| September 17, 2024 | 24.83 |
| September 16, 2024 | 24.34 |
| September 13, 2024 | 25.23 |
| September 12, 2024 | 24.53 |
| September 11, 2024 | 25.44 |
| September 10, 2024 | 23.50 |
| September 09, 2024 | 26.80 |
| September 06, 2024 | 26.00 |
| September 05, 2024 | 26.70 |
| September 04, 2024 | 26.42 |
| September 03, 2024 | 26.23 |
| August 30, 2024 | 26.44 |
| August 29, 2024 | 27.67 |
| August 28, 2024 | 27.31 |
| August 27, 2024 | 26.81 |
| August 26, 2024 | 25.95 |
| August 23, 2024 | 26.02 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.937
Minimum
Mar 23 2020
28.72
Maximum
Jul 25 2024
11.22
Average
9.130
Median
Dec 07 2022
Price to Book Value Benchmarks
| Biogen Inc | 1.548 |
| Alnylam Pharmaceuticals Inc | 1091.96 |
| Biomarin Pharmaceutical Inc | 2.345 |
| Rigel Pharmaceuticals Inc | -- |
| Apellis Pharmaceuticals Inc | 12.89 |
Price to Book Value Related Metrics
| PS Ratio | 6.890 |
| PEG Ratio | -0.9536 |
| Price | 38.76 |
| Earnings Yield | -6.50% |
| Market Cap | 6.113B |
| PEGY Ratio | -0.9536 |